![Global Flow Cytometry Market](https://res.cloudinary.com/devmoveo/image/upload/v1704959575/skyquest/report/phpS1NXY0.jpg)
Report ID: SQMIG35H2031
Report ID:
SQMIG35H2031 |
Region:
Global |
Published Date: August, 2024
Pages:
157
|
Tables:
130 |
Figures:
77
North America led the market with a 41.20% revenue share in 2023, driven by a robust healthcare system and pharmaceutical sector in the U.S., generating high demand for flow cytometry in clinical and research applications. Extensive R&D in therapeutics and increased public-private investments in cancer research have further boosted the need for these instruments. For instance, in December 2023, AlleSense was commissioned to advance cancer diagnostics using cutting-edge technologies, with an initial investment of around USD 2.5 million, significantly contributing to market growth.
The Asia-Pacific flow cytometry market is expected to grow significantly from 2024 to 2030 due to the expanding pharmaceutical and biotechnology sectors in emerging economies like China and India. Market growth is driven by the rising prevalence of chronic diseases and increased use of cytometry devices in various applications. Additionally, continuous innovations in cancer and infectious disease research are projected to significantly contribute to regional market growth. Extensive research activities by regional players aiming to develop innovative flow cytometry solutions are also expected to bolster market expansion in Asia-Pacific during the forecast period.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2031